1-11 of 11
dasatinib
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Meeting the needs of CML patients in resource-poor countries

Hemant Malhotra, Jerald Radich, Pat Garcia-Gonzalez
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 433–442.
https://doi.org/10.1182/hematology.2019000050
Published: 2019
Journal Articles

Cardiovascular care of patients with chronic myeloid leukemia (CML) on tyrosine kinase inhibitor (TKI) therapy

Mary C. Barber, Michael J. Mauro, Javid Moslehi
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 110–114.
https://doi.org/10.1182/asheducation-2017.1.110
Published: 2017
Journal Articles

Which TKI? An embarrassment of riches for chronic myeloid leukemia patients

Timothy Hughes, Deborah White
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 168–175.
https://doi.org/10.1182/asheducation-2013.1.168
Published: 2013
Journal Articles

Initial choice of therapy among plenty for newly diagnosed chronic myeloid leukemia

David Marin
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2012) 2012 (1): 115–121.
https://doi.org/10.1182/asheducation.V2012.1.115.3798209
Published: 2012
Journal Articles

Tyrosine Kinase Inhibitor Use in Pediatric Philadelphia Chromosome–Positive Acute Lymphoblastic Anemia

Stephen P. Hunger
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2011) 2011 (1): 361–365.
https://doi.org/10.1182/asheducation-2011.1.361
Published: 2011
Journal Articles

Educational Session: Managing Chronic Myeloid Leukemia as a Chronic Disease

Andreas Hochhaus
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2011) 2011 (1): 128–135.
https://doi.org/10.1182/asheducation-2011.1.128
Published: 2011
Journal Articles

Mechanisms of resistance to tyrosine kinase inhibitors in chronic myeloid leukemia and recent therapeutic strategies to overcome resistance

Dale Bixby, Moshe Talpaz
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2009) 2009 (1): 461–476.
https://doi.org/10.1182/asheducation-2009.1.461
Published: 2009
Journal Articles

Management of Philadelphia chromosome–positive acute lymphoblastic leukemia (Ph + ALL)

Oliver G. Ottmann, Heike Pfeifer
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2009) 2009 (1): 371–381.
https://doi.org/10.1182/asheducation-2009.1.371
Published: 2009
Journal Articles

Medical Management of CML

Neil P. Shah
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2007) 2007 (1): 371–375.
https://doi.org/10.1182/asheducation-2007.1.371
Published: 2007
Journal Articles

Defining and Managing Imatinib Resistance

Michael J. Mauro
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2006) 2006 (1): 219–225.
https://doi.org/10.1182/asheducation-2006.1.219
Published: 2006
Journal Articles

Loss of Response to Imatinib: Mechanisms and Management

Neil P. Shah
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2005) 2005 (1): 183–187.
https://doi.org/10.1182/asheducation-2005.1.183
Published: 2005